Radiotranscriptomics signature ‐based predictive nomograms for radiotherapy response in patients with nonsmall cell lung cancer: Combination and association of CT features and serum miRNAs levels

ConclusionsThe radiotranscriptomics signature could be an independent biomarker for evaluating radiotherapeutic responses in patients with NSCLC. The radiotranscriptomics signature ‐based nomogram could be used to predict patients’ ORR, which would represent progress in individualized medicine.

Source: Cancer Medicine - May 26, 2020 Category: Cancer & Oncology Authors: Liyuan Fan, Qiang Cao, Xiuping Ding, Dongni Gao, Qiwei Yang, Baosheng Li Tags: ORIGINAL RESEARCH Source Type: research